77 related articles for article (PubMed ID: 24772947)
41. The molecular basis of synergism between carboplatin and ABT-737 therapy targeting ovarian carcinomas.
Jain HV; Meyer-Hermann M
Cancer Res; 2011 Feb; 71(3):705-15. PubMed ID: 21169413
[TBL] [Abstract][Full Text] [Related]
42. In vitro Ultrasonic Potentiation of 2-Phenylethynesulfonamide/Magnetic Fluid Hyperthermia Combination Treatments for Ovarian Cancer.
Mérida F; Rinaldi C; Juan EJ; Torres-Lugo M
Int J Nanomedicine; 2020; 15():419-432. PubMed ID: 32021188
[TBL] [Abstract][Full Text] [Related]
43. Effect of 5-fluorouracil, Optison and ultrasound on MCF-7 cell viability.
Chumakova OV; Liopo AV; Evers BM; Esenaliev RO
Ultrasound Med Biol; 2006 May; 32(5):751-8. PubMed ID: 16677934
[TBL] [Abstract][Full Text] [Related]
44. Cellular sensitization to cisplatin and carboplatin with decreased removal of platinum-DNA adduct by glucose-regulated stress.
Yamada M; Tomida A; Yun J; Cai B; Yoshikawa H; Taketani Y; Tsuruo T
Cancer Chemother Pharmacol; 1999; 44(1):59-64. PubMed ID: 10367750
[TBL] [Abstract][Full Text] [Related]
45. Treatment of transplanted adriamycin-resistant ovarian cancers in mice by combination of adriamycin and ultrasound exposure.
Yu T; Huang X; Hu K; Bai J; Wang Z
Ultrason Sonochem; 2004 Jul; 11(5):287-91. PubMed ID: 15157857
[TBL] [Abstract][Full Text] [Related]
46. Carboplatin resistant human laryngeal carcinoma cells are cross resistant to curcumin due to reduced curcumin accumulation.
Rak S; Cimbora-Zovko T; Gajski G; Dubravčić K; Domijan AM; Delaš I; Garaj-Vrhovac V; Batinić D; Sorić J; Osmak M
Toxicol In Vitro; 2013 Mar; 27(2):523-32. PubMed ID: 23147641
[TBL] [Abstract][Full Text] [Related]
47. Antitumor activity of new organometallic compounds in human ovarian cancer cell lines and comparison to platin derivatives.
Moebus VJ; Stein R; Kieback DG; Runnebaum IB; Sass G; Kreienberg R
Anticancer Res; 1997; 17(2A):815-21. PubMed ID: 9137413
[TBL] [Abstract][Full Text] [Related]
48. Effective cancer cell killing by hydrophobic nanovoid-enhanced cavitation under safe low-energy ultrasound.
Zhao Y; Zhu Y; Fu J; Wang L
Chem Asian J; 2014 Mar; 9(3):790-6. PubMed ID: 24339016
[TBL] [Abstract][Full Text] [Related]
49. Cysteine allows ovarian cancer cells to adapt to hypoxia and to escape from carboplatin cytotoxicity.
Nunes SC; Ramos C; Lopes-Coelho F; Sequeira CO; Silva F; Gouveia-Fernandes S; Rodrigues A; Guimarães A; Silveira M; Abreu S; Santo VE; Brito C; Félix A; Pereira SA; Serpa J
Sci Rep; 2018 Jun; 8(1):9513. PubMed ID: 29934500
[TBL] [Abstract][Full Text] [Related]
50. The promise of sonodynamic therapy.
Trendowski M
Cancer Metastasis Rev; 2014 Mar; 33(1):143-60. PubMed ID: 24346159
[TBL] [Abstract][Full Text] [Related]
51. Improved tumor targeting by regional carboplatin application combined with Gelfoam. An experimental study on liver tumor-bearing rabbits.
Pohlen U; Berger G; Reszka R; Binnenhei M; Buhr HJ
Chemotherapy; 2001; 47(2):143-9. PubMed ID: 11173817
[TBL] [Abstract][Full Text] [Related]
52. Percutaneous catheterization of the peritoneal cavity guided by ultrasonography in the treatment of intraabdominal carcinoma of the ovary.
Bennedbaek O; Bartholdy NJ; Fisker P; Panduro J
Eur J Gynaecol Oncol; 1989; 10(5):300-1. PubMed ID: 2680508
[TBL] [Abstract][Full Text] [Related]
53. Cancer treatment using an optically inert Rose Bengal derivative combined with pulsed focused ultrasound.
Kim YS; Rubio V; Qi J; Xia R; Shi ZZ; Peterson L; Tung CH; O'Neill BE
J Control Release; 2011 Dec; 156(3):315-22. PubMed ID: 21871506
[TBL] [Abstract][Full Text] [Related]
54. Antitumor effect sonodynamically induced by focused ultrasound in combination with Ga-porphyrin complex.
Sasaki K; Yumita N; Nishigaki R; Umemura S
Jpn J Cancer Res; 1998 Apr; 89(4):452-6. PubMed ID: 9617352
[TBL] [Abstract][Full Text] [Related]
55. Electro-sensitisation of mammalian cells and tissues to ultrasound: a novel tumour treatment modality.
Rollan Haro AM; Smyth A; Hughes P; Reid CN; McHale AP
Cancer Lett; 2005 May; 222(1):49-55. PubMed ID: 15837540
[TBL] [Abstract][Full Text] [Related]
56. Analysis of Cell Viability and Gene Expression After Continuous Ultrasound Therapy in L929 Fibroblast Cells.
Bertin LD; Poli-Frederico RC; Pires Oliveira DAA; Oliveira PD; Pires FB; Silva AFS; Oliveira RF
Am J Phys Med Rehabil; 2019 May; 98(5):369-372. PubMed ID: 30489278
[TBL] [Abstract][Full Text] [Related]
57. Distinct sensitivity of normal and malignant cells to ultrasound in vitro.
Lejbkowicz F; Salzberg S
Environ Health Perspect; 1997 Dec; 105 Suppl 6(Suppl 6):1575-8. PubMed ID: 9467085
[TBL] [Abstract][Full Text] [Related]
58. Effects of various modes of sonication with low frequency ultrasound on in vitro survival of human tumor cells.
Sergeeva NS; Sviridova IK; Nikolaev AL; Ambrozevich EG; Kabisov RK; Sarantseva OS; Kurilyak OA; Al'kov SV; Sokolov VV
Bull Exp Biol Med; 2001 Mar; 131(3):279-82. PubMed ID: 11427922
[TBL] [Abstract][Full Text] [Related]
59. Studies of the cavitational effects of clinical ultrasound by sonoluminescence: 4. The effect of therapeutic ultrasound on cells in monolayer culture in a standing wave field.
Pickworth MJ; Dendy PP; Twentyman PR; Leighton TG
Phys Med Biol; 1989 Nov; 34(11):1553-60. PubMed ID: 2587626
[TBL] [Abstract][Full Text] [Related]
60. Synergistic effects of focus ultrasound with different frequency and hematoporphyrin on human tumor cells.
Qi H; Tan S; Ma Y; Song C
Sci China C Life Sci; 1998 Oct; 41(5):520-4. PubMed ID: 18726234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
